234 related articles for article (PubMed ID: 12042200)
1. Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine.
Gothelf D; Falk B; Singer P; Kairi M; Phillip M; Zigel L; Poraz I; Frishman S; Constantini N; Zalsman G; Weizman A; Apter A
Am J Psychiatry; 2002 Jun; 159(6):1055-7. PubMed ID: 12042200
[TBL] [Abstract][Full Text] [Related]
2. Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia.
Kinon BJ; Basson BR; Gilmore JA; Tollefson GD
J Clin Psychiatry; 2001 Feb; 62(2):92-100. PubMed ID: 11247108
[TBL] [Abstract][Full Text] [Related]
3. Weight change and atypical antipsychotic treatment in patients with schizophrenia.
Jones B; Basson BR; Walker DJ; Crawford AM; Kinon BJ
J Clin Psychiatry; 2001; 62 Suppl 2():41-4. PubMed ID: 11232752
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of olanzapine-induced weight gain with reboxetine in patients with schizophrenia: a double-blind, placebo-controlled study.
Poyurovsky M; Isaacs I; Fuchs C; Schneidman M; Faragian S; Weizman R; Weizman A
Am J Psychiatry; 2003 Feb; 160(2):297-302. PubMed ID: 12562576
[TBL] [Abstract][Full Text] [Related]
5. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
[TBL] [Abstract][Full Text] [Related]
6. Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia.
Ascher-Svanum H; Stensland M; Zhao Z; Kinon BJ
BMC Psychiatry; 2005 Jan; 5():3. PubMed ID: 15649317
[TBL] [Abstract][Full Text] [Related]
7. Association of olanzapine-induced weight gain with an increase in body fat.
Eder U; Mangweth B; Ebenbichler C; Weiss E; Hofer A; Hummer M; Kemmler G; Lechleitner M; Fleischhacker WW
Am J Psychiatry; 2001 Oct; 158(10):1719-22. PubMed ID: 11579009
[TBL] [Abstract][Full Text] [Related]
8. Effect of nizatidine on olanzapine-associated weight gain in schizophrenic patients in Korea: a pilot study.
Pae CU; Kim JJ; Lee KU; Lee CU; Bahk WM; Lee SJ; Lee C; Paik IH
Hum Psychopharmacol; 2003 Aug; 18(6):453-6. PubMed ID: 12923823
[TBL] [Abstract][Full Text] [Related]
9. Novel antipsychotics: comparison of weight gain liabilities.
Wirshing DA; Wirshing WC; Kysar L; Berisford MA; Goldstein D; Pashdag J; Mintz J; Marder SR
J Clin Psychiatry; 1999 Jun; 60(6):358-63. PubMed ID: 10401912
[TBL] [Abstract][Full Text] [Related]
10. Extreme weight gain in a youth with schizophrenia: risk/benefit considerations.
Webster D; Devarajan S; Gallant J; Harris A; Kopala LC
Schizophr Res; 2002 Jul; 56(1-2):187-9. PubMed ID: 12084432
[No Abstract] [Full Text] [Related]
11. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial.
Tollefson GD; Beasley CM; Tran PV; Street JS; Krueger JA; Tamura RN; Graffeo KA; Thieme ME
Am J Psychiatry; 1997 Apr; 154(4):457-65. PubMed ID: 9090331
[TBL] [Abstract][Full Text] [Related]
12. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.
Saddichha S; Ameen S; Akhtar S
J Clin Psychopharmacol; 2008 Feb; 28(1):27-31. PubMed ID: 18204337
[TBL] [Abstract][Full Text] [Related]
13. Nizatidine treatment and its relationship with leptin levels in patients with olanzapine-induced weight gain.
Atmaca M; Kuloglu M; Tezcan E; Ustundag B
Hum Psychopharmacol; 2003 Aug; 18(6):457-61. PubMed ID: 12923824
[TBL] [Abstract][Full Text] [Related]
14. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268
[TBL] [Abstract][Full Text] [Related]
15. Body mass index increase of 58% associated with olanzapine.
Bryden KE; Kopala LC
Am J Psychiatry; 1999 Nov; 156(11):1835-6. PubMed ID: 10553757
[No Abstract] [Full Text] [Related]
16. Olanzapine and weight gain.
Isaac MB; Isaac MT
Am J Psychiatry; 2005 Sep; 162(9):1764-5; author reply 1765. PubMed ID: 16135655
[No Abstract] [Full Text] [Related]
17. Weight gain and antipsychotic medications.
Aquila R; Emanuel M
J Clin Psychiatry; 1999 May; 60(5):336-7. PubMed ID: 10362443
[No Abstract] [Full Text] [Related]
18. Olanzapine versus haloperidol treatment in first-episode psychosis.
Sanger TM; Lieberman JA; Tohen M; Grundy S; Beasley C; Tollefson GD
Am J Psychiatry; 1999 Jan; 156(1):79-87. PubMed ID: 9892301
[TBL] [Abstract][Full Text] [Related]
19. A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial.
Sikich L; Hamer RM; Bashford RA; Sheitman BB; Lieberman JA
Neuropsychopharmacology; 2004 Jan; 29(1):133-45. PubMed ID: 14583740
[TBL] [Abstract][Full Text] [Related]
20. Weight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study.
Ratzoni G; Gothelf D; Brand-Gothelf A; Reidman J; Kikinzon L; Gal G; Phillip M; Apter A; Weizman R
J Am Acad Child Adolesc Psychiatry; 2002 Mar; 41(3):337-43. PubMed ID: 11886029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
